Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 204.35
Bid: 204.75
Ask: 204.85
Change: 0.35 (0.17%)
Spread: 0.10 (0.049%)
Open: 202.00
High: 205.00
Low: 199.20
Prev. Close: 204.00
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD

12 Oct 2018 13:25

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 11 October 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,261,631 1.42% 12,060,452 1.52%
(2) Cash-settled derivatives:
11,781,316 1.48% 10,279,200 1.29%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,569,600 1.33% 10,989,600 1.38%
(4)
TOTAL: 33,612,547 4.23% 33,329,252 4.19%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 100 19.7700 USD
ADR Purchase 13,000 19.7784 USD
ADR Purchase 49,154 19.4534 USD
ADR Purchase 54,482 19.4724 USD
ADR Sale 100 19.7700 USD
ADR Sale 25,000 19.4901 USD
ADR Sale 49,154 19.4534 USD
ADR Sale 50,340 19.5716 USD
Ordinary NPV Purchase 82 4,431.4390 JPY
Ordinary NPV Purchase 109 4,426.9357 JPY
Ordinary NPV Purchase 241 4,432.9668 JPY
Ordinary NPV Purchase 251 4,433.9123 JPY
Ordinary NPV Purchase 283 4,427.6466 JPY
Ordinary NPV Purchase 300 4,420.6666 JPY
Ordinary NPV Purchase 300 4,415.5000 JPY
Ordinary NPV Purchase 300 4,410.4666 JPY
Ordinary NPV Purchase 700 4,417.0000 JPY
Ordinary NPV Purchase 727 4,436.4292 JPY
Ordinary NPV Purchase 1,107 4,433.2168 JPY
Ordinary NPV Purchase 2,000 4,432.2250 JPY
Ordinary NPV Purchase 2,100 4,414.6666 JPY
Ordinary NPV Purchase 2,800 4,411.8571 JPY
Ordinary NPV Purchase 3,000 4,413.9333 JPY
Ordinary NPV Purchase 3,500 4,430.6571 JPY
Ordinary NPV Purchase 3,700 4,435.6486 JPY
Ordinary NPV Purchase 3,700 4,410.9189 JPY
Ordinary NPV Purchase 3,800 4,415.1315 JPY
Ordinary NPV Purchase 4,700 4,414.2382 JPY
Ordinary NPV Purchase 4,900 4,416.8489 JPY
Ordinary NPV Purchase 5,100 4,407.7352 JPY
Ordinary NPV Purchase 7,500 4,408.4933 JPY
Ordinary NPV Purchase 9,300 4,435.8924 JPY
Ordinary NPV Purchase 10,100 4,421.9505 JPY
Ordinary NPV Purchase 25,300 4,426.9328 JPY
Ordinary NPV Purchase 30,000 4,420.1633 JPY
Ordinary NPV Purchase 42,700 4,413.3606 JPY
Ordinary NPV Purchase 68,000 4,411.2441 JPY
Ordinary NPV Purchase 86,300 4,406.1112 JPY
Ordinary NPV Purchase 136,200 4,403.5536 JPY
Ordinary NPV Purchase 371,700 4,418.4613 JPY
Ordinary NPV Purchase 381,100 4,416.6775 JPY
Ordinary NPV Purchase 400,400 4,417.1598 JPY
Ordinary NPV Sale 58 4,417.5517 JPY
Ordinary NPV Sale 60 4,389.5666 JPY
Ordinary NPV Sale 117 4,389.0684 JPY
Ordinary NPV Sale 200 4,420.4500 JPY
Ordinary NPV Sale 300 4,420.6666 JPY
Ordinary NPV Sale 411 4,417.6204 JPY
Ordinary NPV Sale 500 4,425.6000 JPY
Ordinary NPV Sale 585 4,400.0598 JPY
Ordinary NPV Sale 800 4,432.5000 JPY
Ordinary NPV Sale 827 4,415.4558 JPY
Ordinary NPV Sale 1,695 4,404.3717 JPY
Ordinary NPV Sale 2,000 4,432.2250 JPY
Ordinary NPV Sale 2,800 4,411.8571 JPY
Ordinary NPV Sale 3,000 4,413.4000 JPY
Ordinary NPV Sale 3,200 4,429.0312 JPY
Ordinary NPV Sale 3,500 4,382.0000 JPY
Ordinary NPV Sale 3,700 4,435.6486 JPY
Ordinary NPV Sale 4,292 4,403.9767 JPY
Ordinary NPV Sale 4,400 4,427.1363 JPY
Ordinary NPV Sale 4,500 4,413.9622 JPY
Ordinary NPV Sale 4,655 4,411.6133 JPY
Ordinary NPV Sale 4,800 4,420.1667 JPY
Ordinary NPV Sale 5,200 4,416.4807 JPY
Ordinary NPV Sale 5,400 4,408.1666 JPY
Ordinary NPV Sale 5,400 4,423.5000 JPY
Ordinary NPV Sale 6,200 4,404.0161 JPY
Ordinary NPV Sale 6,500 4,427.3538 JPY
Ordinary NPV Sale 6,900 4,439.5362 JPY
Ordinary NPV Sale 9,700 4,378.7628 JPY
Ordinary NPV Sale 12,900 4,429.0000 JPY
Ordinary NPV Sale 14,400 4,426.6805 JPY
Ordinary NPV Sale 15,900 4,413.7106 JPY
Ordinary NPV Sale 18,300 4,450.0000 JPY
Ordinary NPV Sale 18,400 4,417.1032 JPY
Ordinary NPV Sale 30,000 4,402.0566 JPY
Ordinary NPV Sale 35,600 4,445.8342 JPY
Ordinary NPV Sale 68,000 4,410.4808 JPY
Ordinary NPV Sale 75,400 4,429.4230 JPY
Ordinary NPV Sale 323,600 4,416.2898 JPY
Ordinary NPV Sale 382,800 4,415.6499 JPY
Ordinary NPV Sale 517,300 4,413.2221 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 58 4,417.5582 JPY
Ordinary NPV SWAP Long 60 4,389.5610 JPY
Ordinary NPV SWAP Long 117 4,389.0610 JPY
Ordinary NPV SWAP Long 411 4,417.6202 JPY
Ordinary NPV SWAP Long 585 4,400.0599 JPY
Ordinary NPV SWAP Long 827 4,415.4562 JPY
Ordinary NPV SWAP Long 1,695 4,404.3719 JPY
Ordinary NPV SWAP Long 4,292 4,403.9766 JPY
Ordinary NPV SWAP Long 4,655 4,411.6132 JPY
Ordinary NPV CFD Long 14,900 4,449.5550 JPY
Ordinary NPV SWAP Short 82 4,431.4431 JPY
Ordinary NPV SWAP Short 109 4,426.9426 JPY
Ordinary NPV SWAP Short 241 4,432.9743 JPY
Ordinary NPV SWAP Short 251 4,433.9144 JPY
Ordinary NPV SWAP Short 283 4,427.6477 JPY
Ordinary NPV SWAP Short 727 4,436.4304 JPY
Ordinary NPV SWAP Short 1,107 4,433.2176 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 12 Oct 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 48,000 4625.0000 European 12 Oct 2018
Ordinary NPV Call Options Purchased 82,000 5264.7000 European 25 Oct 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -48,000 4625.0000 European 12 Oct 2018
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4620.0372 European 6 Nov 2018
Ordinary NPV Call Options Written -10,000,000 4620.0372 European 6 Nov 2018
Ordinary NPV Put Options Purchased -10,000,000 4620.0372 European 6 Nov 2018
Ordinary NPV Put Options Written 10,000,000 4620.0372 European 6 Nov 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181012005216/en/

Copyright Business Wire 2018

Date   Source Headline
26th Apr 20246:15 pmRNSPublication of Suppl.Prospcts
26th Apr 20244:00 pmRNSPublication of a Prospectus
26th Apr 20243:03 pmRNSForm 8.3 - Wincanton plc
26th Apr 20243:02 pmRNSForm 8.3 - Virgin Money UK plc
26th Apr 20243:01 pmRNSForm 8.3 - Tritax Big Box REIT plc
26th Apr 20243:00 pmRNSForm 8.3 - UK Commercial Property REIT Limited
26th Apr 20242:57 pmRNSForm 8.3 - Spirent Communications plc
26th Apr 20242:54 pmRNSForm 8.3 - Tyman plc
26th Apr 20242:54 pmRNSForm 8.3 - Quanex Building Products Corporation
26th Apr 20242:50 pmRNSForm 8.3 - Network International Holdings plc
26th Apr 20242:48 pmRNSForm 8.3 - Mattioli Woods plc
26th Apr 20242:45 pmRNSForm 8.3 - Lok’n Store Group plc
26th Apr 20242:44 pmRNSForm 8.3 - Kin and Carta plc
26th Apr 20242:42 pmRNSForm 8.3 - International Paper Company
26th Apr 20242:40 pmRNSForm 8.3 - Smith (DS) plc
26th Apr 20242:14 pmRNSForm 38.5(b)-Irish Residential Properties REIT plc
26th Apr 202411:50 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
26th Apr 202411:47 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
26th Apr 202411:46 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
26th Apr 202411:44 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
26th Apr 202411:42 amRNSForm 8.5 (EPT/NON-RI) - BHP Group Limited
26th Apr 202411:41 amRNSForm 8.5 (EPT/NON-RI) - Anglo American plc
26th Apr 20247:30 amRNSTransaction in Own Shares
25th Apr 20242:45 pmRNSForm 8.3 - Wincanton plc
25th Apr 20242:43 pmRNSForm 8.3 - Virgin Money UK plc
25th Apr 20242:41 pmRNSForm 8.3 - UK Commercial Property REIT Limited
25th Apr 20242:40 pmRNSForm 8.3 - Tritax Big Box REIT plc
25th Apr 20242:38 pmRNSForm 8.3 - Spirent Communications plc
25th Apr 20242:36 pmRNSForm 8.3 - Tyman plc
25th Apr 20242:34 pmRNSForm 8.3 - Quanex Building Products Corporation
25th Apr 20242:32 pmRNSForm 8.3 - Network International Holdings plc
25th Apr 20242:30 pmRNSForm 8.3 - Mattioli Woods plc
25th Apr 20242:18 pmRNSForm 8.3 - Lok’n Store Group plc
25th Apr 20242:16 pmRNSForm 8.3 - Kin and Carta plc
25th Apr 20242:13 pmRNSForm 8.3 - International Paper Company
25th Apr 20242:12 pmRNSForm 8.3 - Smith (DS) plc
25th Apr 202410:48 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
25th Apr 202410:46 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
25th Apr 202410:43 amRNSForm 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd
25th Apr 202410:42 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
25th Apr 202410:41 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
25th Apr 202410:39 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
25th Apr 20247:30 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNS1st Quarter Results
24th Apr 20246:29 pmRNSDisposal of Italian mortgage portfolio
24th Apr 20242:41 pmRNSForm 8.3 - Wincanton plc
24th Apr 20242:39 pmRNSForm 8.3 - Virgin Money UK plc
24th Apr 20242:38 pmRNSForm 8.3 - UK Commercial Property REIT Limited
24th Apr 20242:36 pmRNSForm 8.3 - Tritax Big Box REIT plc
24th Apr 20242:34 pmRNSForm 8.3 - Spirent Communications plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.